EU committee positive opinion on Kuvan approval in Europe. Should get final approval within 90 days. I sold this in the last 2 weeks raising cash (reported in another thread). Out currently. MM have been using as a cash machine currently. They keep using these bios for cash to solve their liquidity problems.
Will look to get back in sometime in the next quarter if the financial world settles out so I can have real confidence in the market. Don't right now.
Three selling drugs (double digit growth), orphan exclusivisity (nobody else can sell an equivelent for 7 years), and over 500 million in cash. Not bad for a baby bio growing up.
At some point I believe Genzyme may buy this out. Hope its not in the next 30-60 days? Thats a risk I am taking.
Kutz